Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters









Database
Language
Publication year range
1.
Further hearing loss during osteoporosis treatment with etidronate.
Yasil, S; Cömlekçi, A; Güneri, A.
Postgrad Med J ; 74(872): 363-4, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9799894

ABSTRACT

Ototoxicity is a rare and disabling complication in bisphosphonate therapy. Here we describe two patients who encountered further hearing loss during oral etidronate treatment for osteoporosis.


Subject(s)
Etidronic Acid/adverse effects , Hearing Loss, Sensorineural/etiology , Osteoporosis, Postmenopausal/drug therapy , Aged , Etidronic Acid/therapeutic use , Female , Follow-Up Studies , Hearing Loss, Sensorineural/chemically induced , Humans , Otosclerosis/complications
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL